Theranos Herpes Simplex Virus-1 IgG Assay
Jul 2015
232d
Theranos, Inc.
1
Total
1
Cleared
0
Denied
Theranos, Inc. — FDA 510(k) Submissions
Theranos, Inc. has submitted 1 FDA 510(k) premarket notifications since 2015, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1 . Use the specialty filter in the sidebar to narrow results.
1 devices